Elucidating the exact pharmacological mechanism of action (MOA) of naturally taking place compounds may be complicated. Though Tarselli et al. (sixty) formulated the first de novo synthetic pathway to conolidine and showcased this naturally occurring compound effectively suppresses responses to the two chemically induced and inflammation-derived pa